Artigo
Revisado por pares
Phase I–II and pharmacokinetic study combining gemcitabine (GEM) with oxaliplatin (OX) in patients (pts) with advanced non-small-cell lung (NSCLC) and ovarian carcinoma (OC)
2001; Elsevier BV; Volume: 37; Linguagem: Inglês
10.1016/s0959-8049(01)80740-1
ISSN1879-0852
AutoresSandrine Faivre, Éric Raymond, François Lokiec, Christian Monnerat, S. Novello, P. Pautier, C. Lhommé, L. Kayitalire, P. Armand, Thierry Le Chevalier,
Tópico(s)Lung Cancer Research Studies
Referência(s)